REVACEPT Trademark

Trademark Overview

On Tuesday, July 6, 2010, a trademark application was filed for REVACEPT with the United States Patent and Trademark Office. The USPTO has given the REVACEPT trademark a serial number of 79085052. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Sunday, February 20, 2022. This trademark is owned by Corimmun GmbH. The REVACEPT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations and substances in the nature of drugs, all for the treatment and prevention of cardiovascular diseases; Veterinary preparations and substances in the nature of drugs, all for small or large animals with cardiovascular diseases; fusion proteins for pharmaceutical purposes, namely, for the treatment and prevention of cardiovascular disorders; cardiovascular treatment preparations; pharmaceutical preparations for the treatment or prevention of cardiovascular disorders

Fusion proteins being diagnostic reagents and proteins for use in ELISA kits for scientific, research, radiology, ultrasound, sonography, plaque imaging, and nuclear medicine use; proteins for use in science, namely, protein arrays for scientific research
revacept

General Information

Serial Number79085052
Word MarkREVACEPT
Filing DateTuesday, July 6, 2010
Status706 - SECTION 71 ACCEPTED
Status DateSunday, February 20, 2022
Registration Number3991844
Registration DateTuesday, July 12, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances in the nature of drugs, all for the treatment and prevention of cardiovascular diseases; Veterinary preparations and substances in the nature of drugs, all for small or large animals with cardiovascular diseases; fusion proteins for pharmaceutical purposes, namely, for the treatment and prevention of cardiovascular disorders; cardiovascular treatment preparations; pharmaceutical preparations for the treatment or prevention of cardiovascular disorders
Goods and ServicesFusion proteins being diagnostic reagents and proteins for use in ELISA kits for scientific, research, radiology, ultrasound, sonography, plaque imaging, and nuclear medicine use; proteins for use in science, namely, protein arrays for scientific research
Translation of Words in MarkThe wording "REVACEPT" has no meaning in a foreign language.

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, July 2, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 2, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameadvanceCor GmbH
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressMartinsried 82152
DE
Party NameCorimmun GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameCorimmun GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameCorimmun GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Monday, February 21, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sunday, February 20, 2022REGISTERED-SEC.71 ACCEPTED
Wednesday, February 2, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 8, 2021TEAS SECTION 71 RECEIVED
Thursday, August 6, 2020INTERNATIONAL REGISTRATION RENEWED
Sunday, July 12, 2020COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Monday, July 2, 2018NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, July 2, 2018REGISTERED-SEC.71 ACCEPTED
Monday, July 2, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 2, 2018REINSTATED
Monday, July 2, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 18, 2018CANCELLED SECTION 71
Friday, May 18, 2018REINSTATED
Friday, May 18, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 16, 2018CANCELLED SECTION 71
Wednesday, July 5, 2017TEAS SECTION 71 RECEIVED
Wednesday, July 5, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 12, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, June 15, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 1, 2015CHANGE OF OWNER RECEIVED FROM IB
Monday, July 21, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 27, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 12, 2012FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 12, 2012FINAL DISPOSITION PROCESSED
Wednesday, October 12, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 12, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, April 26, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2011PUBLISHED FOR OPPOSITION
Wednesday, April 6, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 6, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 23, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 17, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 17, 2011EXAMINER'S AMENDMENT ENTERED
Thursday, March 17, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 17, 2011EXAMINERS AMENDMENT E-MAILED
Thursday, March 17, 2011EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 16, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 16, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 16, 2011ASSIGNED TO LIE
Friday, March 4, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 4, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 4, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 2, 2011ASSIGNED TO EXAMINER
Saturday, November 13, 2010REFUSAL PROCESSED BY IB
Friday, October 22, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 22, 2010REFUSAL PROCESSED BY MPU
Friday, October 22, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 21, 2010NON-FINAL ACTION WRITTEN
Monday, October 18, 2010ASSIGNED TO EXAMINER
Tuesday, August 17, 2010APPLICATION FILING RECEIPT MAILED
Friday, August 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 12, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

revacept cardiovascular treatment proteins preparations prevention pharmaceutical research namely scientific fusion